Silence Therapeutics plc (SLN) — research page

US · us-cm-kg/NASDAQ/SLN · as of 2026-11-08

Identity and listing

Silence Therapeutics plc is listed on NASDAQ under ticker SLN. Its ISIN is US82686Q1013 and its LEI is 213800SSURRJBX85SQ91. Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United Kingdom. Its listing status is listed, not halted.

The disclosure read

The record holds 51 filings in the twelve months to 2026-11-08, across 27 filing days. The median gap between filing days is 6.5 days, against a NASDAQ median of 6.0 days and a sector median of 6.0 days. The latest filing is dated 2026-11-05 and is of type regulatory_filing, 3 days before the record date. The NASDAQ median latency is 5.0 days and the sector median latency is 4.0 days. The NASDAQ median filing count is 52 and the sector median filing count is 63.0.

window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is PricewaterhouseCoopers LLP, located in Reading, United Kingdom. The record holds no auditor changes.

Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.

Orderability

The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The issuer's own investor-relations page names 7 research houses: Chardan, Cantor, Goldman Sachs, H.C. Wainwright & Co., LLC, Jefferies LLC, Morgan Stanley and William Blair.

Open research

No openly published research notes were found on the record.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

As-of depth

The record holds sealed filings for the issuer in the years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

Sources

10 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1

https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)

10.2

https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)

10.3

https://data.sec.gov/submissions/CIK0001479615.json (identity.jurisdiction)

10.4

https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)

10.5

https://mcp.us-cm-kg.ai/events/NASDAQ/SLN (the disclosure lines)

10.6

https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)

10.7

https://www.sec.gov/Archives/edgar/data/1479615/000119312526092591/sln-20251231.htm (the auditor)

10.8

https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)

10.9

https://silence-therapeutics.com/investors/share-information/analyst-coverage-key-advisers/default.aspx (coverage)

10.10

https://mcp.us-cm-kg.ai/record/NASDAQ/SLN (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US82686Q1013"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:9caa320064322b89.